ADAI Symposium: High THC Cannabis in Legal Regulated Markets
Symposium Resources
The Addictions, Drug & Alcohol Institute’s Cannabis Education & Research Program hosted this day-long hybrid (in-person and virtual) event on September 16, 2022.
The symposium was focused on the short and long-term risks of high-THC products, including conversations about policy-focused solutions and ways to increase awareness through education campaigns for providers, parents, and youth, and featured a range of international, national, and regional speakers, as well as local policymakers.
Recordings & Slides for Each Session
Symposium Opening Remarks
- Jürgen Unützer, MD, MPH, MA, Professor, Department Chair, Psychiatry and Behavioral Sciences
- Susan Ferguson, PhD, Director, Addictions, Drug & Alcohol Institute (ADAI), University of Washington
- Beatriz Carlini, PhD, MPH, Director, ADAI Cannabis Education and Research Program
Keynote: Market Trends in High Potency Cannabis
Professor of Operations Research and Public Policy, Carnegie Mellon University’s Heinz College
Morning panel: Short- and Long-Term Risks of High THC Products [watch]
Introductions: State Rep. Lauren Davis (D-Shoreline)
Moderator: Tracy Klein, PhD, ARNP, FAANP, FRE, FAAN (Assistant Director, Center for Cannabis Policy, Research and Outreach, Washington State University)
- High THC Products: Public Health Outcomes in Legal Markets
Julia Dilley, PhD (University of Washington)
[watch | slides]
- Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition
Carrie Cuttler, PhD (Washington State University)
[watch | slides] - Cannabis Use by Young Adults: Trends and Considerations
Jason Kilmer, PhD (University of Washington)
[watch | slides] - Cannabis Use and Psychiatric Comorbidity: Epidemiology and Association with High-Potency Cannabis Products
Deborah Hasin, PhD (Columbia University)
[watch | slides] - Recommendations for Regulating High Potency Cannabis in Recreational Markets and Why
Rosalie Pacula, PhD (University of Southern California)
[watch | slides] - Q&A with complete panel [watch]
Keynote: High THC Cannabis Products: Trends in Consumer Use, Adverse Outcomes, and Implications for Policy in Legal Cannabis Markets
David Hammond, PhD, Professor, University Research Chair, School of Public Health Sciences, University of Waterloo
Comments from Policymakers
- State Rep. Lauren Davis (D-Shoreline)
- State Rep. Shelley Kloba (D-Kirkland)
- State Sen. Jesse Salomon (D-Shoreline)
Afternoon panel: Exploring Solutions: Addressing the Risks of High THC Cannabis Products
Introductions: Jim Vollendroff, MPA (Washington Liquor and Cannabis Board)
Moderator: Marina Epstein, PhD (University of Washington)
- Do Cannabis Users Reduce THC Doses When Using More Potent Cannabis Products?
Wayne Hall, PhD (University of Queensland, Australia)
[watch | slides]
- Regulatory Considerations and Challenges for Cannabis Products with High THC Concentration
Gillian Schauer, PhD, MPH (University of Washington)
[watch | slides] - Risk of High Concentration THC for Young Adults with Psychosis: Cannabis Intervention Implications
Denise Walker, PhD (University of Washington)
[watch | slides] - How to Address High THC Cannabis Products’ Risks and Harms: Perspectives of Washington Stakeholders
Beatriz Carlini, PhD, MPH (University of Washington)
[watch | slides] - Q&A with complete panel [watch]
https://youtu.be/eWhWl3oL8n8?t=3437
Closing remarks
- Beatriz Carlini, PhD, MPH, Director, ADAI Cannabis Education and Research Program
